Difficulty of interpreting disease-free interval curves when substantial numbers of patients die in remission
Sanz, M.A.; Sánchez-Durán, A.; Martín, G.
Cancer Treatment Reports 69(7-8): 924-925
1985
ISSN/ISBN: 0361-5960 PMID: 4016801 Document Number: 261475
Document emailed within 1 workday
Related Documents
Jonk, A.; Kroon, B.B. 1990: The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma Netherlands Journal of Surgery 42(6): 161-162Anderlini, P.; Ghaddar, H.M.; Smith, T.L.; Pierce, S.; Kantarjian, H.M.; O'Brien, S.; Keating, M.J.; Freireich, E.J.; Estey, E.H. 1996: Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first Leukemia 10(6): 964-969
2007: E2902: A Phase III randomized study of farnesyl transferase inhibitor R115777 in acute myeloid leukemia patients in second or subsequent remission or in remission after primary induction failure or patients over age 60 in first remission Clinical Advances in Hematology and Oncology: H&o 5(1): 13-14
Rainey, J.M.; Pohl, R.B.; Bilolikar, S.G. 1982: The QT interval in drug-free depressed patients Journal of Clinical Psychiatry 43(5 Part 2): 39-40
Kamiyoshihara, M.; Hirai, T.; Kawashima, O.; Morishita, Y. 1997: Pulmonary metastasis from breast cancer: a case report with 19-year disease-free interval Kyobu Geka. Japanese Journal of Thoracic Surgery 50(3): 194-196
Li, A.; Wang, H.; Zuo, Q.; Fu, C. 2016: Analysis of the factors in the disease-free interval of metachronous pulmonary metastasis from rectal cancer Zhonghua Wei Chang Wai Ke Za Zhi 19(5): 562-565
Heise, E.; Görlich, M. 1982: Estradiol receptor activity in human breast cancer, disease free interval and survival time Anticancer Research 2(1-2): 33-36
Griffith, C.D.; Ellis, I.O.; Bell, J.; Burns, K.; Blamey, R.W. 1990: Density of lymphocytic infiltration of primary breast cancer does not affect short-term disease-free interval or survival Journal of the Royal College of Surgeons of Edinburgh 35(5): 289-292
Musgrave, S.; Dickerman, J.D.; Land, V.J. 1986: Second or subsequent remission with a disease-free survival of 5 years or longer in acute lymphocytic leukemia of childhood: results of a national survey Pediatrics 77(5): 765-769
Caldarola, L.; Calderini, P.; Volterrani, P.; Di Carlo, F.; Gaglia, P. 1983: The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancer Italian Journal of Surgical Sciences 13(3): 179-185
Lippman, M.E.; Allegra, J.C. 1980: Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval Cancer 46(12 Suppl): 2829-2834
Khan, T.; Armstrong, D.G. 2018: Ulcer-free, hospital-free and activity-rich days: three key metrics for the diabetic foot in remission Journal of Wound Care 27(Suppl 4): S3-S4
Reiniger, G.; Rudolph, W. 1985: Therapy of coronary heart disease with nitroglycerin patches. Behavior of anti-ischemic effectiveness in continuous administration and following patch free interval Herz 10(5): 305-311
Wainwright, R.J.; Foran, J.P.; Padaria, S.F.; Akhras, F.; Jackson, G.; Clark, A.R. 1993: The long-term safety and tolerability of transdermal glyceryl trinitrate, when used with a patch-free interval in patients with stable angina British Journal of Clinical Practice 47(4): 178-182
Andersen, S.; Lindqvist, B.; Nyström, L. 1982: Prognosis curves for patients with polycystic kidney disease Annals of Clinical Research 14(2): 90-92
Nishiyama, M.; Nakae, K.; Kuriyama, T.; Hashimoto, M.; Hsu, Z-Ning. 2002: A study among related pairs of Japanese patients with familial Behçet's disease: group comparisons by interval of disease onsets Journal of Rheumatology 29(4): 743-747
Mata, J.M.; Kershenobich, D.; Villarreal, E.; Rojkind, M. 1975: Serum free proline and free hydroxyproline in patients with chronic liver disease Gastroenterology 68(5 Pt 1): 1265-1269
Bonomi, P.; Gale, M.; Von Roenn, J.; Anderson, K.; Johnson, P.; Wolter, J.; Economou, S. 1988: Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen Seminars in Oncology 15(2 Suppl 1: 26-33
Yang, X.-y. 2013: Interpreting IgG4 related disease and unnamed disease from the aspect of non infection non tumor inflammatory disease Zhonghua Yi Xue Za Zhi 93(13): 964-965
Katoh, T.; Endoh, N.; Takamizawa, H. 1982: The study for the standard of the remission of the patients with trophoblastic disease Nihon Sanka Fujinka Gakkai Zasshi 34(4): 511-520